Rephonic
Artwork for Research To Practice

Research To Practice | Oncology Videos

Dr Neil Love
Prostate Cancer
Chronic Lymphocytic Leukemia
Immunotherapy
Ovarian Cancer
PARP Inhibitors
Endometrial Cancer
Diffuse Large B-Cell Lymphoma
Antibody-Drug Conjugates
Colorectal Cancer
Pembrolizumab
Multiple Myeloma
Bispecific Antibodies
Small Cell Lung Cancer
Follicular Lymphoma
HER2
Low-Grade Serous Ovarian Cancer
Breast Cancer
Gastroesophageal Cancer
Non-Small Cell Lung Cancer
Cdk4-6 Inhibitors

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

PublishesDailyEpisodes1524Founded13 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Research To Practice

Latest Episodes

Featuring a slide presentation and related discussion from Prof Rakesh Popat, including the following topics:

• Overview of GPRC5D in multiple myeloma (0:00)

• Key findings from the Phase I/II MonumenTAL-1 clinical trial (2:01)

• Key findings... more

Featuring an interview with Dr Matthew Lunning, including the following topics:

• Tafasitamab for follicular lymphoma (0:00)

• frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)

CME information... more

Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:

• Introduction (0:00)

• Prologue: Saturday Night Fever (1:35)

• Baby Boomers' Guide to Mechanisms of Action (3:07)

• Second-Line Treatment (12:36... more

Where We Are, Where We're Headed: Bispecific Antibodies in the Management of Follicular Lymphoma | Faculty Presentation 2: Emerging Bispecific Antibody Strategies for Follicular Lymphoma — Dr Matasar

CME information and select publications

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Matthew Lunning
Medical oncologist specializing in lymphoma
Fred and Pamela Buffett Cancer Center
Episode: Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens
Matthew Matasar
Chief of blood disorders at Rutgers Cancer Institute and medical oncologist
Rutgers Cancer Institute
Episode: Diffuse Large B-Cell Lymphoma — A Grand Rounds Program
Erica Mayer
Medical oncologist at Dana-Farber Cancer Institute specializing in breast cancer
Dana-Farber Cancer Institute
Episode: Hormone Receptor-Positive Localized Breast Cancer — A Grand Rounds Activity
Lindsey Roeker
Clinical investigator at Mayo Clinic
Mayo Clinic
Episode: Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6
Daniel Erman
Clinical investigator at the University of Utah Huntsman Cancer Institute
University of Utah Huntsman Cancer Institute
Episode: Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6
Shazia Nakoda
Clinical investigator at Fox Chase Cancer Center
Fox Chase Cancer Center
Episode: Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6
Shannon Westin
Gynecologic oncologist at the MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: Ovarian Cancer — Microlearning Activity 4: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Nicoletta Colombo
Professor at the European Institute of Oncology IRCCS
European Institute of Oncology IRCCS
Episode: Ovarian Cancer — Microlearning Activity 4: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Gottfried Konecny
Physician at the David Geffen School of Medicine at UCLA
David Geffen School of Medicine at UCLA
Episode: Ovarian Cancer — Microlearning Activity 4: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Host

Neil Love
Medical oncologist and oncology program moderator

Reviews

4.6 out of 5 stars from 157 ratings
  • Still the best and still addicted!

    I am a retired pharmacist and my husband still listens with me. Dr. Love is the best at getting to what is important for day to day treatment. Soooo good I can’t give it up. Thank you all for continuing be an inspiration to this old woman. In my next life……….❤️

    Apple Podcasts
    5
    Redbat7
    United States2 months ago
  • Valued resource

    Relentless in its focus on the general medical oncolgist. An important resource.

    Apple Podcasts
    5
    a h/o
    United States5 years ago
  • Excellent

    Since my fellowship training Neil Love has made these presentations the best of the best in staying UpToDate with current and future practice

    Apple Podcasts
    5
    obete man
    United States5 years ago
  • RTP is is consistently great

    Research to Practice continues to put out well produced clinically relevant content from expert faculty that is applicable to daily oncology practice. It is an invaluable resource for me.

    Apple Podcasts
    5
    OKMedStudent
    United States6 years ago
  • Gold standard

    I’m not an oncologist but I love listening to all of these podcasts. I have to imagine that Neil Love is an absolute giant in this field. So interesting and informative.

    Apple Podcasts
    5
    Bob a la sob mob
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Clinicians describe the content as clinically relevant, useful for general medical oncology and applicable to daily practice.
The expert faculty and coverage of current and future practice are valued by listeners seeking to stay up to date.
Listeners value Neil Love's ability to focus discussions on practical, day-to-day treatment decisions.
Listeners praise the production quality and find the material informative even outside oncology practice.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#223
United States/Science
Apple Podcasts
#60
China/Science
Apple Podcasts
#157
Brazil/Science
Apple Podcasts
#185
Hong Kong/Science
Apple Podcasts
#225
South Africa/Science
Apple Podcasts
#232
Israel/Science

Talking Points

Recent interactions between the hosts and their guests.

Diffuse Large B-Cell Lymphoma — A Grand Rounds Program
Q: Do you use preemptive IVIG in patients getting bispecifics? Would you consider stopping epcoritamab in a patient who has a complete response? Do the bispecifics have CNS activity?
Matasar generally offers IVIG when hypogammaglobulinemia develops, including for some patients with IgG levels between 400 and 600. He says stopping epcoritamab after a complete response can be considered through an individual discussion, though he generally follows the studied continuous-treatment approach. He notes initial reports of CNS penetration and says bispecifics may be used for relapsed CNS lymphoma.
Diffuse Large B-Cell Lymphoma — A Grand Rounds Program
Q: Would you consider the FRONT-MIND strategy in a patient with a GCB, a diffuse large B-cell lymphoma?
Matasar says the trial showed progression-free survival benefit in both GCB and non-GCB disease, but no overall survival benefit in either group. He considers discussing it with patients reasonable, though he remains reluctant to use it routinely because of the added burden.
Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens
Q: Where are we right now in terms of the use of targeted therapy, where are we heading, and how do you manage patients who are very, very elderly like this one?
Lunning discusses testing for TP53 mutations, using BTK inhibitors with rituximab in older patients, and evaluating whether treatment can be stopped after response. He also outlines possible BTK, BCL2, and CD20 combinations for high-risk disease.
Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens
Q: What are your thoughts about the results for antibody-drug conjugate and bispecific antibody combinations, and how do you see the future of these combinations?
Lunning describes early results as promising but says clinicians need more follow-up, especially to understand efficacy in high-risk patients, and to determine whether these regimens can move into earlier treatment settings.
Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 4
Q: So again, it's been interesting to hear this discussion in high grades here. It's also interesting this lady had a great response to the O-Agin endocrine therapy, getting back to what we were talking about before, that you do see some patients like that. But what about, I mean, I guess at this point, theoretically, we know you think about TdxD and low-grade serous. I mean, there's so few in high-grade serous, I imagine we don't, I don't know if you ever used TdxD and low-grade serous, and if you had this situation and you could give both, what would you do?
Banerjee says she has not used trastuzumab deruxtecan for low-grade serous ovarian cancer. She would generally consider a MEK inhibitor or avutometinib and defactinib before an HER2-directed antibody-drug conjugate, depending on the patient's molecular profile and available evidence.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Research To Practice

What is Research To Practice about and what kind of topics does it cover?

Clinical interviews, case reviews, journal clubs and symposium discussions examine advances in solid tumors and hematologic cancers. Medical oncologist Neil Love leads many conversations with specialist clinicians and researchers, while roundtables bring together multiple experts to compare approaches to challenging cases. Topics range from treatment selection and sequencing to clinical trial results, biomarker testing, adverse-effect management and the practical use of emerging therapies. The emphasis is on translating current evidence into decisions relevant to oncology practice, including care in community settings as well as academic centers. Short microlearning formats sit alongside longer presentations and event proceedings, making th... more

Where can I find podcast stats for Research To Practice?

Rephonic provides a wide range of podcast stats for Research To Practice. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Research To Practice and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Research To Practice get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Research To Practice, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Research To Practice?

Rephonic provides comprehensive predictive audience data for Research To Practice, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Research To Practice have?

To see how many followers or subscribers Research To Practice has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Research To Practice?

These podcasts share a similar audience with Research To Practice:

1. Oncology Brothers: Practice-Changing Cancer Discussions
2. Two Onc Docs
3. Oncology Today with Dr Neil Love
4. Plenary Session
5. Breast Cancer Update

How many episodes of Research To Practice are there?

Research To Practice launched 13 years ago and published 1524 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Research To Practice?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Research To Practice?

Rephonic pulls ratings and reviews for Research To Practice from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Research To Practice?

Rephonic provides full transcripts for episodes of Research To Practice. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Research To Practice?

Recent guests on Research To Practice include:

1. Matthew Lunning
2. Matthew Matasar
3. Erica Mayer
4. Lindsey Roeker
5. Daniel Erman
6. Shazia Nakoda
7. Shannon Westin
8. Nicoletta Colombo

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days